糖尿病患者过渡至透析期间低血糖相关住院与死亡率的关系
该观察性队列研究纳入30156例美国退伍军人糖尿病患者,分析透析前低血糖相关住院与透析后全因死亡的关系。结果显示透析前低血糖住院与透析后死亡风险升高相关,且住院次数越多死亡风险越高;含磺脲类和/或胰岛素的方案与低血糖风险升高相关。
要点
- 透析前低血糖相关住院与透析后全因死亡风险升高独立相关(aHR 1.25)。
- 低血糖住院次数越多,透析后死亡风险呈剂量依赖性升高。
- 含磺脲类和/或胰岛素的降糖方案与透析前低血糖风险升高相关。
核心结论
- 在合并糖尿病的透析患者中,透析前低血糖相关住院频率与透析后全因死亡呈剂量依赖性关系。
主要发现
- 透析前低血糖相关住院与透析后全因死亡风险升高相关,校正后HR为1.25(95%CI 1.17-1.34),参照组为无低血糖住院。
- 低血糖相关住院1次、2次、3次及以上的校正后HR分别为1.21(95%CI 1.12-1.30)、1.47(95%CI 1.19-1.82)、2.07(95%CI 1.46-2.95),参照组为无低血糖住院。
- 与未使用口服降糖药和胰岛素的患者相比,含磺脲类和/或胰岛素的方案与低血糖风险升高相关。
临床怎么用
- 对糖尿病合并慢性肾脏病过渡至透析的患者,应关注透析前低血糖事件史,其与透析后死亡风险升高相关。
- 选用降糖方案时需权衡磺脲类和胰岛素相关的低血糖风险。
局限性
- 不能排除残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Diabetic patients with declining kidney function are at heightened risk for hypoglycemia. We sought to determine whether hypoglycemia-related hospitalizations in the interval before dialysis therapy initiation are associated with post-end-stage renal disease (ESRD) mortality among incident patients with ESRD with diabetes. STUDY DESIGN: Observational cohort study. SETTING & PARTICIPANTS: US veterans from the national Veterans Affairs database with diabetes and chronic kidney disease transitioning to dialysis therapy from October 2007 to September 2011. EXPOSURE: Hypoglycemia-related hospitalizations during the pre-ESRD period and antidiabetic medication regimens. OUTCOME: The outcome of post-ESRD all-cause mortality was evaluated relative to pre-ESRD hypoglycemia. The outcome of pre-ESRD hypoglycemia-related hospitalization was evaluated relative to antidiabetic medication regimens. ANALYTIC APPROACH: We examined whether the occurrence and frequency of pre-ESRD hypoglycemia-related hospitalizations are associated with post-ESRD mortality using Cox regression models adjusted for case-mix covariates. In a subcohort of patients prescribed 0 to 2 oral antidiabetic drugs and/or insulin, we examined the 12 most commonly prescribed antidiabetic medication regimens and risk for pre-ESRD hypoglycemia-related hospitalization using logistic regression models adjusted for case-mix covariates. RESULTS: Among 30,156 patients who met eligibility criteria, the occurrence of pre-ESRD hypoglycemia-related hospitalization(s) was associated with higher post-ESRD mortality risk: adjusted HR (aHR), 1.25; 95% CI, 1.17-1.34 (reference group: no hypoglycemia hospitalization). Increasing frequency of hypoglycemia-related hospitalizations was independently associated with incrementally higher mortality risk: aHRs of 1.21 (95% CI, 1.12-1.30), 1.47 (95% CI, 1.19-1.82), and 2.07 (95% CI, 1.46-2.95) for 1, 2, and 3 or more hypoglycemia-related hospitalizations, respectively (reference group: no hypoglycemia hospitalization). Compared with patients who were prescribed neither oral antidiabetic drugs nor insulin, medication regimens that included sulfonylureas and/or insulin were associated with higher risk for hypoglycemia. LIMITATIONS: Residual confounding cannot be excluded. CONCLUSIONS: Among incident patients with ESRD with diabetes, a dose-dependent relationship between frequency of pre-ESRD hypoglycemia-related hospitalizations and post-ESRD mortality was observed. Further study of diabetic management strategies that prevent hypoglycemia as patients with chronic kidney disease transition to ESRD are warranted.
引用
- Rhee CM, Kovesdy CP, You AS, et al. Hypoglycemia-Related Hospitalizations and Mortality Among Patients With Diabetes Transitioning to Dialysis. Am J Kidney Dis. 2018. PMID: 30037725. doi:10.1053/j.ajkd.2018.04.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。